Nanoparticles could deliver drugs to the brain
For patients with malignant brain tumors, the prognosis remains dismal. With the most aggressive treatments available, patients are usually only expected to live about 14 months after a diagnosis.
This is because, chemotherapy, the most common form of treatment for cancer, is uniquely challenging for brain tumor patients. The delicate organ in our skulls is protected by a network of vessels and tissue called the blood-brain barrier that keeps most foreign substances out. Furthermore, chemotherapy drugs can cause significant damage to the rest of the body if they are not able to target the tumor in a pharmacologically significant dose.
These challenges have plagued scientists for years, but a team of researchers for Yale School of Medicine and Beijing Normal University just published a breakthrough study detailing a new method that offers a promise at treatment. The solution? Nanoparticles.
Nanoparticles, particles that are smaller than wavelengths of visible light and can only be seen under a special microscope, have the potential to pass through the blood-brain barrier. They can also carry drugs to targeted areas of the body, reducing the side effects on the rest of the body. But previous nanoparticles were very complex and not very efficient in penetrating in the brain.
This most recent paper, published in Nature Biomedical Engineering on March 30, 2020, describes a small carbon nanoparticle engineered by the two labs that could both deliver chemotherapy drugs across the blood-brain barrier and mark tumor cells with fluorescence in mice. What’s more, this nanoparticle is incredibly simple—made up of only one single compound.
We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.
“The major problems we’ve solved is to improve the delivery efficiency and specificity of nanoparticles,” says Jiangbing Zhou, PhD, associate Professor of Neurosurgery and of Biomedical Engineering at Yale School of Medicine. “We created nanoparticles like building a missile. There’s usually a GPS on every missile to guide it into a specific location and we’re able to guide particles to penetrate the brain and find tumors.”
The GPS-like targeting occurs because the nanoparticles engineered to be recognized by a molecule called LAT1, which is present in the blood-brain barrier as well as many tumors, but not in most other normal organs. As a result, chemotherapy drugs can be loaded on the dots and target tumors while barely affecting the rest of the body. The nanoparticles gain entry to the brain because they’ve been engineered to look like amino acids, which are allowed past the blood-brain barrier as nutrients.
The nanoparticles have wider implications than drug delivery. They can be stimulated to emit a fluorescence, which helps surgeons locate tumor to remove with greater accuracy.
Still, there’s a long road ahead before this research can be applied in a clinical setting, says Dr. Zhou. “It takes a long time before the technology can be translated into clinical applications,” he says. “But this finding suggests a new direction for developing nanoparticles for drug delivery to the brain by targeting LAT1 molecules.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Brain cancer treatment
- Researchers develop new tools to assess care provided for patients with brain metastasison October 6, 2020 at 10:56 pm
Ambitious efforts at UVA Cancer Center to improve care delivered to patients with cancer that has spread to the brain have yielded important insights and tools that can benefit other hospitals, a new ...
- Queensland Health Minister investigates 'distressing' brain cancer exemption caseon October 6, 2020 at 6:51 pm
Queensland's Deputy Premier investigates reports the Health Department told a brain cancer patient to catch a taxi or Uber to receive chemotherapy treatment while in hotel quarantine in Brisbane.
- Brain Tumor Diagnosis and Treatments Market 2020 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2026on October 6, 2020 at 10:40 am
New Study Reports “Brain Tumor Diagnosis and Treatments Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. This report provides in ...
- Fort Worth Fire engineer dies due to work-related brain canceron October 6, 2020 at 1:06 am
Steve Collins was a family man who was married to his wife, Carla, for 19 years. They have two sons, ages 15 and 12.
- Terminally ill toddler with brain tumour gains extra time with family thanks to new cancer treatmenton October 5, 2020 at 9:30 pm
Bawalan was expected to die in 2017 but gained another precious year at home with her family after a new targeted drug treatment matched her cancer's genetic code.
Go deeper with Google Headlines on:
Brain cancer treatment
Go deeper with Bing News on:
Carbon nanoparticle drug delivery
- Nanoparticle-Based Vaccineson October 5, 2020 at 5:10 am
Nanoparticle-based vaccines exhibit a wide range of advantageous physicochemical properties that can aid in the targeted delivery of novel vaccines.
- Polymers in Controlled Drug Deliveryon September 27, 2020 at 5:00 pm
Chien YW, Novel Drug Delivery Systems, New York, Marcel Dekker, 1982. Domb AJ (ed), Polymeric Site-Specific Pharmacotherapy, Chichester, UK, Wiley, 1994. Donbrow M (ed), Microcapsules and ...
- Graphene Facemask to Deactivate Coronaviruses and Bacteriaon September 14, 2020 at 9:54 am
They produced the material by passing an infrared laser over a carbon ... work in drug delivery, investigating the potential of injectable hydrogels to deliver cells, drugs and nanoparticles ...
- MGMR, a next-generation carbon nanotube, solves drug development challengeson September 3, 2020 at 10:19 pm
BioPact’s MGMR (Medical Grade Molecular Rebar) offers a safe and scalable nanoparticle platform for controlled and targeted delivery of a wide range of therapeutics.
- Nanodelivery Strategies in Cancer Chemotherapyon September 2, 2020 at 5:00 pm
Here, we present cancer drug delivery strategies that ... solid lipid nanoparticles, polymeric nanoparticles, dendrimers, carbon nanotubes and magnetic nanoparticles. As the cardinal features ...